Letters Risks of gene therapy should be weighed against lack of alternatives for many diseases BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7494.791-a (Published 31 March 2005) Cite this as: BMJ 2005;330:791 Article Related content Metrics Responses Peer review Related articles Clinical Review Recent developments in gene transfer: risk and ethics Published: 06 January 2005; BMJ 330 doi:10.1136/bmj.330.7482.79 See more Constitutional symptoms in a young person BMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781 An adolescent with disabling abdominal pain BMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101 Andrew Wakefield calls Trump “on our side” over vaccines after meeting BMJ December 05, 2016, 355 i6545; DOI: https://doi.org/10.1136/bmj.i6545 Doctors in Pakistan call for workers deported from the UAE to be screened for HIV BMJ December 05, 2016, 355 i6544; DOI: https://doi.org/10.1136/bmj.i6544 Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Cited by... The road to providing human embryo stem cells for therapeutic use: the UK experience.Abstract Fulltext PDF